Entries by Phil Case

AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020

FOR IMMEDIATE RELEASE AnPac Bio Reports Record Q1 for Paid CDA-Based Cancer Testing Volume in 2021, Increasing Approximately 130% Compared to Q1, 2020 San Jose, CA, April 16, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused […]

AnPac Bio Developed and Completed Evaluations of New Generation Cancer Detection Sensor with Improved Performance

AnPac Bio Developed and Completed Evaluations of  New Generation Cancer Detection Sensor with Improved Performance San Jose, CA, March 9, 2021 – AnPac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that […]

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement

AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement San Jose, CA, March 5, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today that on March 4, 2021, the Company […]

China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility)

China’s NMPA Approved Starting of Registration Testing of AnPac Bio Class III Medical Device (For Lung Cancer Auxiliary Diagnosis Utility) San Jose, CA, February 8, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening […]

AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection | Continues to Innovate and Build Strong IP Portfolio

FOR IMMEDIATE RELEASE AnPac Bio Granted a New US patent on Novel Medical Device for Multi-Cancer Detection |  Continues to Innovate and Build Strong IP Portfolio San Jose, CA, February 1, 2021 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the […]

AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases

AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases andRecorded Over 20 Types of Pre-cancer Diseases San Jose, CA, December 14, 2020 – AnPac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today […]

Anpac Bio Announces Change of Auditor

Anpac Bio Announces Change of Auditor San Jose, CA, December 4, 2020 – Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today the resignation of Ernst & Young Hua Ming LLP (“EY”), […]

Anpac Bio Announces Appointment of New Independent Director

Anpac Bio Announces Appointment of New Independent Director San Jose, CA, November 16, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that Professor Jianhua Shao has been appointed as an independent director and a member […]

AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing

FOR IMMEDIATE RELEASE AnPac Bio US Completes COVID-19 Antibody Test Verification and Approved to Begin Commercial Testing San Jose, CA, November 10, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that the Company has completed […]

©2019 Anpac Bio-Medical Science Co., Ltd.